Search Constraints
Search Results
Select an image to start the slideshow
Resolving Alzheimer’s Disease Heterogeneity Through Proteome-Based Subtyping
1 of 40
TEM characterization of helical amyloid filaments in Alzheimer’s disease human brain comparing disease progression rates
2 of 40
Consequences of locus coeruleus degeneration in a rat model of Alzheimer’s disease
3 of 40
Proteomic profiling of the cerebrospinal fluid of African Americans and Caucasians reveals common and unique biomarkers of Alzheimer’s disease
4 of 40
Plasma biomarkers of Alzheimer’s disease and related dementia for the prediction of hippocampal atrophy amongst adults in Kinshasa, Democratic Republic of Congo
5 of 40
Evaluating the Role of Curli and Gut Escherichia coli Enrichment on Alzheimer’s Disease Outcomes in the 5xFAD Mouse Model
6 of 40
Seeding of synthetic amyloid-β(1-42) monomers by amyloid-β(1-42) present in Alzheimer’s brains
7 of 40
The Impacts of Gut Bacteroides thetaiotaomicron Exposure on Cognitive Impairment and Aβ Pathology in the 5xFAD Alzheimer’s disease Mouse Model
8 of 40
Correlation between biomarkers associated with Alzheimer's disease and the cognitive practice effect
9 of 40
Ten-Eleven Translocation Proteins-Mediated Epigenetic Regulation in Alzheimer’s Disease
10 of 40
Locus coeruleus physiology in physiology in Alzheimer’s disease
11 of 40
Noradrenergic dysfunction in neurodegenerative disease
12 of 40
Integrated Proteomics to Understand the Role of Neuritin (NRN1) as a mediator of Cognitive Resilience to Alzheimer’s Disease
13 of 40
Characterizing the Molecular Mechanisms Underlying the Health Effects of Fine Particulate Matters among Susceptible Populations via Multi-Omics Analysis
14 of 40
Neural codes underlying memory and flexible navigation in health and Alzheimer’s disease
15 of 40
Association between Fine Particulate Matter Exposure and Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease among a Cognitively Healthy Population-based Brain Cohort
16 of 40
Salivary Lactoferrin as a Robust Biomarker of Alzheimer’s Disease
17 of 40
Molecular Biomarkers in a Cohort of Middle-Aged African Americans and Caucasians with a Family History of Alzheimer’s Disease
18 of 40
Alzheimer's Disease Pathology Imputation and Risk Prediction Using Clinical Indices
19 of 40
High-fat Diet-induced Diabetes Couples to Alzheimer’s Disease through Inflammation-activated C/EBPb/AEP Pathway
20 of 40
An Investigation of the domain-domain interactions of A Disintegrin Metalloproteinase domain-containing protein 10 (ADAM10)
21 of 40
Continuity of Care and Functional Decline among Older Adults with Alzheimer’s Disease and Related Dementias
22 of 40
The Effect of Occupational Cognitive Complexity on the Risk of Alzheimer’s Disease Mortality in the State of Georgia
23 of 40
Experiences of Caregivers of Dementia Patients with an Integrated Primary Care Model
24 of 40
Applying Genome-Wide Association Study to Analyze Novel Variants That Potentially Relate to Alzheimer’s Disease
25 of 40
An Investigation of the Role of the Histone Demethylase LSD1, and Its Disordered Domain, in Neuronal Maintenance and Tau-Mediated Neurodegeneration
26 of 40
Prion Delivery via Peptide-Nucleic Acid Co-assembly: the Inside-out Virus
27 of 40
Time-dependent determination of inflammatory mediators in a 5xFADmouse model of Alzheimer's disease
28 of 40
Effect of M1 Muscarinic Receptor Activators on Locomotion in Rats
29 of 40
Cellular Trafficking and molecular heterogeneity of amyloid beta seeds. How similar are beta amyloid aggregates and prions?
30 of 40
Evidence that pathological Tau functions through inhibition of lysine-specific demethylase 1A in tauopathy model mice
31 of 40
Diet may be a Modifiable Risk Factor for Cognitive Decline in African Americans and Caucasians at High Risk for Developing Alzheimer's Disease: A Pilot Study of the Southern and Prudent Diets.
32 of 40
Next Generation Proteomics in the Nervous System
33 of 40
Characterization of naturally occurring, pathogenic and benignAβ multimers Why don't monkeys get Alzheimer'sdisease?
34 of 40
Peripheral immune traffic to the AD brain: role of soluble TNF
signaling and peripheral inflammation
35 of 40
Examining Elevated Stress Levels Among African American Caregivers
of Relatives with Dementia
36 of 40
Effects of selective allosteric activation of M1 and M4 muscarinic
receptors on object recognition memory performance in rats
37 of 40
Investigating the Effects of Specific Acetylcholine Receptor
Activation on Hippocampal Function for the Treatment of Alzheimer's
Disease
38 of 40
Conformational evolution in amyloid self-assembly
39 of 40
Comprehensive Proteome and Transcriptome Studies Reveal RNA
Processing Dysfunction in Alzheimer's disease
40 of 40